In May 2018, ThinkWell released findings from a systematic review of the evidence base on immunization delivery costs (IDC) in low- and middle-income countries (LMICs). The review aimed to answer a question frequently asked by global and country immunization stakeholders: What are the unit costs of vaccine delivery across different LMICs and through a variety of delivery strategies?
The review and a subsequent refresh considered over 15,000 resources published between January 2005 and January 2018 on the topic. Ultimately, the review drew from 61 resources with IDC data on a variety of vaccines, delivery strategies, types of cost analysis, and settings.
Have you ever wondered what it costs to deliver the HPV vaccine in schools in Indonesia? Are you looking for evidence on operational costs to inform your country’s immunization program? Have you been searching for the cost of mobile vaccine delivery in Uganda, Peru, or Bangladesh? Our new and improved set of resources has this information and more. Explore it all on our website, www.immunizationeconomics.org/ican. Here you’ll find:
- A standardized and richly annotated Immunization Delivery Cost Catalogue (IDCC) of the data extracted. The IDCC (Excel workbook and web tool) includes 410 unit costs (i.e. cost per capita, dose, fully immunized child, full immunization of a vaccine, or person in the target population), all presented in 2016 US dollars for easy referencing and use.
- A summary report of immunization delivery cost findings. The report describes the spread and scope of the evidence, methods, and resources, including a quality assessment of the resources captured in the systematic review.
- A set of immunization delivery cost ranges for vaccine delivery through a variety of strategies and in a range of contexts. These estimates of cost per dose and cost per fully immunized child combine four or more comparable unit cost estimates into a single cost range with other descriptive statistics noted.
- Companion interpretive products (e.g., detailed methodology note and user guides)
Across these resources, the team has added new data, addressed feedback obtained from user research, and considered new approaches to analyzing the data. The changes are meant to better equip you—whether you’re a policymaker, researcher, or international partner—with evidence to guide country and global immunization and health system policy, planning, advocacy, etc.